United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023

1. Executive Summary

2. United States Non–Invasive Prenatal Testing(NIPT) Market Analysis (2015 – 2023)

• 2.1 Overall Actual NIPT Test Volume & Forecast
  • 2.1.1 Average Risk Actual NIPT Test Volume & Forecast
  • 2.1.2 High Risk Actual NIPT Test Volume & Forecast
• 2.2 Overall Potential NIPT Test Volume & Forecast
  • 2.2.1 Average Risk Potential NIPT Test Volume & Forecast
  • 2.2.2 High Risk Potential NIPT Test Volume & Forecast
• 2.3 Overall Actual NIPT Test Market Revenue & Forecast
  • 2.3.1 Average Risk Actual NIPT Test Market Revenue & Forecast
  • 2.3.2 High Risk Actual NIPT Test Market Revenue & Forecast
• 2.4 Overall Potential NIPT Test Market Revenue & Forecast
  • 2.4.1 Average Risk Potential NIPT Test Market Revenue & Forecast
  • 2.4.2 High Risk Potential NIPT Test Market Revenue & Forecast

3. Key Drivers and Inhibitors of the United States NIPT Test Market

• 3.1 Market Drivers
• 3.2 Inhibitors

4. United States NIPT Test Market: Reimbursement & Regulation System

• 4.1 Reimbursement System
• 4.2 Regulation System

5. Non–Invasive Prenatal Testing (NIPT) Implementation – High–Income Countries

• 5.1.1 Clinical Issues
• 5.1.2 Ethical Issues
• 5.1.3 Legal and Regulatory Issues

6. Competitive Landscape

• 6.1 Non–Invasive Prenatal Testing(NIPT) – Comparative Analysis
• 6.2 Non–Invasive Prenatal Testing – Collaboration Deals
  • 6.2.1 Year 2007
  • 6.2.2 Year 2013
  • 6.2.3 Year 2014
  • 6.2.4 Year 2015
  • 6.2.5 Year 2016
  • 6.2.6 Year 2017
• 6.3 Non–Invasive Prenatal Testing – Venture Capital Investment
  • 6.3.1 Year 2011
  • 6.3.2 Year 2012
  • 6.3.3 Year 2013
  • 6.3.4 Year 2015
• 6.4 Non–Invasive Prenatal Testing – Merger and Acquisition
  • 6.4.1 Year 2013
  • 6.4.2 Year 2014
  • 6.4.3 Year 2016
• 6.5 Non–Invasive Prenatal Testing – Exclusive Agreement
  • 6.5.1 Year 2008
  • 6.5.2 Year 2013
  • 6.5.3 Year 2014
  • 6.5.4 Year 2015
  • 6.5.5 Year 2016
• 6.6 Non–Invasive Prenatal Testing – Licensing Agreement
  • 6.6.1 Year 2007
  • 6.6.2 Year 2011
  • 6.6.3 Year 2013
  • 6.6.4 Year 2014
  • 6.6.5 Year 2015
• 6.7 Non–Invasive Prenatal Testing – Distribution Agreement
  • 6.7.1 Year 2012
  • 6.7.2 Year 2013
  • 6.7.3 Year 2014
• 6.8 Non–Invasive Prenatal Testing – Partnership Deals
  • 6.8.1 Year 2013
  • 6.8.2 Year 2014
  • 6.8.3 Year 2015

7. Key Companies Analysis

• 7.1 Sequenom Laboratories (LabCorp)
  • 7.1.1 Business Overview
  • 7.1.2 NIPT Test Portfolio
  • 7.1.3 NIPT Test Analysis (Volume and Value)
    • 7.1.3.1 Overall NIPT Test Volume & Forecast
    • 7.1.3.2 Overall NIPT Test Market Revenue & Forecast
  • 7.1.4 Sequenom Diagnostics – International Distributors
  • 7.1.5 NIPT Test - Latest Development & Trends
• 7.2 Ariosa Diagnostics (Roche)
  • 7.2.1 Business Overview
  • 7.2.2 NIPT Test Portfolio
  • 7.2.3 NIPT Test Analysis (Volume and Value)
    • 7.2.3.1 Overall NIPT Test Volume & Forecast
    • 7.2.3.2 Overall NIPT Test Market Revenue & Forecast
  • 7.2.4 NIPT Test - Latest Development & Trends
• 7.3 Illumina
  • 7.3.1 Business Overview
  • 7.3.2 NIPT Test Portfolio
  • 7.3.3 NIPT Test Analysis (Volume and Value)
    • 7.3.3.1 Overall NIPT Test Volume & Forecast
    • 7.3.3.2 Overall NIPT Test Market Revenue & Forecast
  • 7.3.4 NIPT Test - Latest Development & Trends
• 7.4 Natera
  • 7.4.1 Business Overview
  • 7.4.2 NIPT Test Portfolio
  • 7.4.3 NIPT Test Analysis (Volume and Value)
    • 7.4.3.1 Overall NIPT Test Volume & Forecast
    • 7.4.3.2 Overall NIPT Test Market Revenue & Forecast
  • 7.4.4 NIPT Test - Latest Development & Trends
• 7.5 Quest Diagnostics
  • 7.5.1 Business Overview
  • 7.5.2 NIPT Test Portfolio